Dr. Michael Feigin Michael Feigin, PhD

Michael Feigin

PhD

Specializing In:

Cancer cell signaling Cancer genetics Three dimensional cell culture Cell biology

Special Interests:

G-protein coupled receptor signaling Noncoding mutations in cancer Pancreatic cancer Breast cancer Melanoma

About Michael Feigin

Positions

Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Department of Pharmacology & Therapeutics

Background

Education and Training:

  • PhD - Stony Brook University, Molecular and Cellular Pharmacology

Fellowship:

  • Cold Spring Harbor Laboratory, Cancer Biology

Research

Research Overview:

Our lab seeks to understand the molecular causes of cancer to develop better therapies and improve patient outcome. Through a combination of computational and experimental methods, we study how genes are regulated in cancer, and how changes in gene regulation and cell signaling networks drive tumor progression.

Learn More


Publications

Full Publications list on PubMed
  • Feigin ME*, Garvin T*, Bailey P, Waddell N, Chang DK, Shuai S, Gallinger S, McPherson JD, Grimmond SM, Khurana E, Stein LD, Biankin AV, Schatz MC, Tuveson DA. Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma. Nature Genetics. 2017
  • Boj SF, Hwang C, Baker LA, Chio IIC, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, Gracanin A, Oni T, Yu KH, van Boxtel R, Huch M, Rivera KD, Wilson JP, Feigin ME, Öhlund D, Handly-Santana A, Ardito-Abraham CM, Ludwig M, Elyada E, Alagesan B, Biffi G, Yordanov GN, Delcuze B,Creighton B, Wright K, Park Y, Morsink FHM, Molenaar IQ, Rinkes IHB, Cuppen E, Hao Y, Jin Y, Nijman IJ, Iacobuzio-Donahue C, Leach SD, Pappin DJ, Hammell M, Klimstra DS, Basturk O, Hruban RH, Offerhaus GJ, Vries RGJ, Clevers H, Tuveson DA. Organoid models of human and mouse ductal pancreatic cancer. Cell. 160(1-2), 324-38, 2015
  • Feigin ME, Xue B, Hammell MC, Muthuswamy SK. G-protein-coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion. PNAS. 111(11), 4191-4196, 2014
  • Feigin ME, Akshinthala SD, Araki K, Rosenberg AZ, Muthuswamy LB, Martin B, Lehmann BD, Berman HK, Pietenpol JA, Cardiff RD, Muthuswamy SK. Mislocalization of the polarity protein Scribble promotes mammary tumorigenesis and is associated with basal breast cancer. Cancer Research. 74(11), 3180-3194, 2014
  • Feigin ME. Harnessing the genome for characterization of GPCRs in cancer pathogenesis. (Review) FEBS Journal. 280, 4729-4738, 2013

*Co-first authors

Request an Appointment

Make an appointment by calling 1-800-ROSWELL (1-800-767-9355)

Make an Appointment